104 related articles for article (PubMed ID: 11189505)
1. [Changes of thyroid and adrenocortical functions after bone marrow transplantation with MAC conditioning regimen in leukemia patients].
Ma Y; Qiao Z; Yang L
Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):402-4. PubMed ID: 11189505
[TBL] [Abstract][Full Text] [Related]
2. [Effect of bone marrow transplantation conditioning regimen on thyroid and adrenocortical functions in patients with blood diseases].
Feng S; Yan W; Han M; Qiu L; Yan Y; Han J
Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):147-50. PubMed ID: 15622777
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.
Carpenter PA; Marshall GM; Giri N; Vowels MR; Russell SJ
Bone Marrow Transplant; 1996 Sep; 18(3):489-94. PubMed ID: 8879607
[TBL] [Abstract][Full Text] [Related]
4. TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission.
Biagi E; Rovelli A; Balduzzi A; De Lorenzo P; Tagliabue A; Uderzo C
Bone Marrow Transplant; 2000 Dec; 26(11):1260-2. PubMed ID: 11149746
[No Abstract] [Full Text] [Related]
5. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
[TBL] [Abstract][Full Text] [Related]
6. [Outcome of autologous bone marrow transplantation in 73 patients with acute leukemia].
Han M; Feng S; Li C
Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):422-4. PubMed ID: 11189510
[TBL] [Abstract][Full Text] [Related]
7. Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia.
Porcellini A; Manna A; Moretti L; Carotenuto M; Greco MM; Bodenizza C
Bone Marrow Transplant; 1989 May; 4(3):331-3. PubMed ID: 2659120
[No Abstract] [Full Text] [Related]
8. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S
Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
[TBL] [Abstract][Full Text] [Related]
10. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
Burke JM; Caron PC; Papadopoulos EB; Divgi CR; Sgouros G; Panageas KS; Finn RD; Larson SM; O'Reilly RJ; Scheinberg DA; Jurcic JG
Bone Marrow Transplant; 2003 Sep; 32(6):549-56. PubMed ID: 12953125
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
12. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants.
Al-Fiar FZ; Colwill R; Lipton JH; Fyles G; Spaner D; Messner H
Bone Marrow Transplant; 1997 May; 19(10):1019-22. PubMed ID: 9169646
[TBL] [Abstract][Full Text] [Related]
13. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
Martín A; Pérez-Simón JA; Caballero MD; López-Holgado N; Vázquez L; del Cañizo MC; San Miguel JF
Haematologica; 2005 Jan; 90(1):78-85. PubMed ID: 15642673
[TBL] [Abstract][Full Text] [Related]
14. Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang study.
Deconinck E; Hunault M; Milpied N; Bernard M; Renaud M; Desablens B; Delain M; Witz F; Lioure B; Pignon B; Guyotat D; Berthou C; Jouet JP; Casassus P; Ifrah N; Boiron JM
Biol Blood Marrow Transplant; 2005 Jun; 11(6):448-54. PubMed ID: 15931633
[TBL] [Abstract][Full Text] [Related]
15. Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia.
Russell S; Vowels M
Transplant Proc; 1992 Feb; 24(1):183. PubMed ID: 1539236
[No Abstract] [Full Text] [Related]
16. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sharathkumar A; Saunders EF; Dror Y; Grant R; Greenberg M; Weitzman S; Chan H; Calderwood S; Freedman MH; Doyle J
Bone Marrow Transplant; 2004 Jan; 33(1):39-45. PubMed ID: 14566329
[TBL] [Abstract][Full Text] [Related]
17. Relationship between circulating cytokine levels and thyroid function following bone marrow transplantation.
Lee WY; Kang MI; Oh KW; Oh ES; Baek KH; Lee KW; Kim SW; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2004 Jan; 33(1):93-8. PubMed ID: 14704661
[TBL] [Abstract][Full Text] [Related]
18. A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Uehara T; Nakaseko C; Yokota A; Saito Y; Nishimura M
Am J Hematol; 2002 Sep; 71(1):37-40. PubMed ID: 12221672
[TBL] [Abstract][Full Text] [Related]
19. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP
Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128
[TBL] [Abstract][Full Text] [Related]
20. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]